2022 annual financial data
Zentalis Pharmaceuticals 2022 Operating cash flow growth
Direct answer
Operating cash flow growth was -6.27%.
Operating income was -227,287,000 USD and net income was -236,806,000 USD.
Operating cash flow was -163,751,000 USD.
Get free Zentalis Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -227,287,000 USD
- Net income
- -236,806,000 USD
- Operating cash flow
- -163,751,000 USD